Over the four-week period ending 6 March 2021, an estimated 1.1 million people in private
households in the UK reported experiencing long COVID (symptoms persisting more than …

An estimated 962,000 people living in private households in the UK (1.5% of the population)
were experiencing self-reported" long COVID"(symptoms persisting for more than four …

Experimental estimates of the prevalence of symptoms that remain 12-weeks after
coronavirus (COVID-19) infection (commonly referred to as" long COVID") range from 3.0 …

Multiple studies across global populations have established the primary symptoms
characterising Coronavirus Disease 2019 (COVID-19) and long COVID. However, as …

Background Commonly reported symptoms of long COVID may have different patterns of
prevalence and presentation across different countries. While some limited data have been …

Background Long Covid is a public health concern that needs defining, quantifying, and
describing. We aimed to explore the initial and ongoing symptoms of Long Covid following …

Background Long COVID, describing the long-term sequelae after SARS-CoV-2 infection,
remains a poorly defined syndrome. There is uncertainty about its predisposing factors and …

Long-COVID prevalence estimates vary widely and should take account of symptoms that
would have occurred anyway. Here we determine the prevalence of symptoms attributable …

Long COVID remains a broadly defined syndrome, with estimates of prevalence and
duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n= 508,707; …

The impact of long COVID is increasingly recognised, but risk factors are poorly
characterised. We analysed questionnaire data on symptom duration from 10 longitudinal …